Full View

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

TR Pedersen, AG Olsson, O Færgeman, J Kjekshus… - Circulation, 1998 - Am Heart Assoc
Background—The Scandinavian Simvastatin Survival Study (4S) randomized 4444 patients
with coronary heart disease (CHD) and serum cholesterol 5.5 to 8.0 mmol/L (213 to 310 …
被引用次数：874 相关文章

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

TR Pedersen, AG Olsson, O Faergeman, J Kjekshus… - Circulation, 1998 - europepmc.org
Background The Scandinavian Simvastatin Survival Study (4S) randomized 4444 patients
with coronary heart disease (CHD) and serum cholesterol 5.5 to 8.0 mmol/L (213 to 310 …

Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

TR Pedersen, AG Olsson, O Færgeman, J Kjekshus… - Circulation, 1998 - cir.nii.ac.jp
< jats: p>< jats: italic> Background</jats: italic>—The Scandinavian Simvastatin Survival
Study (4S) randomized 4444 patients with coronary heart disease (CHD) and serum …
[PDF] academia.edu

[PDF][PDF] Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

TR Pedersen, AG Olsson, O Færgeman, J Kjekshus… - 1998 - academia.edu
Background—The Scandinavian Simvastatin Survival Study (4S) randomized 4444 patients
with coronary heart disease (CHD) and serum cholesterol 5.5 to 8.0 mmol/L (213 to 310 …

[引用][C] Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

TR PEDERSEN, AG OLSSON… - … (New York, NY), 1998 - pascal-francis.inist.fr
Author PEDERSEN, T. R 1; OLSSON, A. G 2; MIETTINEN, T 9; CHRISTOPHERSEN, B 4;
TOBERT, J. A 10; MUSLINER, T. A 10; COOK, T. J 10; FAERGEMAN, O 3; KJEKSHUS, J 4; …
[PDF] psu.edu

[PDF][PDF] Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

TR Pedersen, AG Olsson, O Færgeman, J Kjekshus… - 1998 - Citeseer
Background—The Scandinavian Simvastatin Survival Study (4S) randomized 4444 patients
with coronary heart disease (CHD) and serum cholesterol 5.5 to 8.0 mmol/L (213 to 310 …

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

TR Pedersen, AG Olsson, O Faergeman… - …, 1998 - pubmed.ncbi.nlm.nih.gov
Background The Scandinavian Simvastatin Survival Study (4S) randomized 4444 patients
with coronary heart disease (CHD) and serum cholesterol 5.5 to 8.0 mmol/L (213 to 310 …

[引用][C] Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian simvastatin survival study (4S)

P TR - Circulation, 1998 - cir.nii.ac.jp
Lipoprotein changes and reduction in the incidence of major coronary heart disease events
in the Scandinavian simvastatin survival study (4S) | CiNii Research CiNii 国立情報学研究所 …
[PDF] academia.edu

[PDF][PDF] Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

TR Pedersen, AG Olsson, O Færgeman, J Kjekshus… - 1998 - academia.edu
Background—The Scandinavian Simvastatin Survival Study (4S) randomized 4444 patients
with coronary heart disease (CHD) and serum cholesterol 5.5 to 8.0 mmol/L (213 to 310 …

[引用][C] changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

TR PEDERSEN, AG OLSSON… - …, 1998 - Lippincott Williams & Wilkins